Dr.Dumasia(Bavaji)the stock market bioscope

2023-02-19 18:04:29 Open / Comment

2023-02-19 18:04:28 Strong stocks from nifty 200 are

ITC
POLYCAB
PERSISTENT
CUMMINS
ZYDUS LIFE
BRITANNIA
OIL
SIEMENS
M&MFIN
LT
INDIAN BANK
JINDAL STEL

Please note.... strong stocks list shows stocks having strong momentum...

This list is useful for momentum investment and not useful for mean reversal investment. Open / Comment

2023-02-19 18:04:28 Weekend study of strength and weakness of nifty 200 stocks.

Picture remains same as previous week.

Stocks having strong upside momentum 5 and  downside decreased to 15.

Same way... stocks with overall upside momentum at 22 downside momentum at 46.

Overall still downside momentum outnumbered upside momentum stocks. Open / Comment

2023-02-19 15:07:22 Dalal Street 13-26 Feb 2023.pdf Open / Comment

2023-02-19 15:05:03 *MONEY TIMES TALK*
*Dated 19 February 23*

*Dishman Carbogen’s* Q3 NP rose 33% YoY to Rs.46.946 cr. led by revenue growth of 14% to Rs.640 cr. Add.

Specialty Chemicals co., *TGV SRAAC,* posted 112% higher Q3 NP YoY and may post FY23 EPS of Rs 42. It trades at a PE of just 2.92x against industry average of 47x and P/B ratio of just 1.33x against industry average of 8.72x. Strong re-rating is in store.

*NALCO* posted Q3 NP of Rs.274 cr. as against Rs.170 cr. YoY. Although profit margins was hit, it registered a robust growth in production on all fronts. Accumulate.

Although *Bharat Dynamics’* Q3 was affected due to delays in receipt of critical electronic components, it looks good as alternate sources are being evaluated. Add on dips.

*Oil India* posted its best-ever Q3 with NP of Rs.2284.41 cr. A second interim dividend of Rs.10 has also been declared. Add.

*Sarda Energy & Minerals*’ Q3 EPS fell to Rs.36.99 from Rs.46.34 YoY. The share looks attractive at a P/BV ratio of 1.20x and a PE ratio of 6.35x. Add in small quantities.

Analysts believe *M&M* may sustain its outperformance driven by consistency in the automotive and tractor divisions with higher economies of scale. Add in small quantities.

*Nykaa* PAT declined 71% YoY to Rs.8.5 cr. in Q3, in spite of a rise in revenue by 33% to Rs.1463 cr. Sell.

*Adani group* is scouting for $1.5bn of ‘confidence capital’ from Abu Dhabi Investment Authority and other major investors. Better stay away from all Adani shares for now.

Since UK faces depleting ammunition reserves given the Ukraine-Russia war, Indian defense cos. *MTAR, HAL, and Mazagon Docks Shipbuilders* must be accumulated as 75% of our armaments would be sourced from Indian companies.

Brokerage firm, Jefferies, maintains that *RIL* has a 33% upside in one year, aided by its renewable energy business and other verticals. Add for the long term.

*ITC* to export up to Rs.2000 cr. worth of raw tobacco in FY24. The other divisions of ITC are also Accumulate.

*PFC’s* Q3 NP of Rs.5241.1 cr. led to an EPS of Rs.14.76 and Rs.42.47 for 9MFY23 and a third interim dividend of Rs.3.50. An FY23 EPS of Rs.57+ and a final dividend of Rs.7+ is a distinct possibility. The share is also a bonus candidate. Buy.

*Biocon* is in talks with PE investors to sell a stake in its arm to prune its debts and fund its acquisition of Viatris Inc. The share is available at a reasonable price. Accumulate.

Packaging dynamics are changing. While *Polyplex and Cosmo Films* posted subdued results, Uflex and Jindal Polyfilms posted losses. Hold the first two and exit the other two.

*Hero MotorCorp* to boost exports to 10% of sales. Add for the long term.

*MIDHANI’s* order book stands at Rs.1400 cr., which includes 40% from the defense sector. New orders worth Rs.500+ cr. likely from MOUs signed. Add.

*Amrutanjan* is facing serious allegations of financial malpractices. It also delivered unpleasant results for Q3. Sell.

*Bharat Electronics* and Israel Aerospace Industries to manufacture its Lora weapon systems for the Indian armed forces. Positive for the company. Add.

*Shilpa Medicare* has registered its Bengaluru facility with the UAE authorities to manufacture and test its Orodispersible films and Transdermal systems. Add in small lots.

Minda Corp has acquired 15.7% stake in Pricol for Rs.400 cr. Add *Pricol* at current rates.

*Geekay* notched 226% higher Q3 EPS of Rs.5.9 and 131% higher 9M EPS of Rs.11.5 and is all set to garner FY23 EPS of Rs.16+, backed by huge demand for its products. Buy for 30% gain.

*Repco Home Finance* posted 138% higher Q3 EPS of Rs.13.3 and 51% higher 9M EPS of Rs.37.1, which may lead to FY23 EPS of Rs.47+. Buy for 30% gain.

*Karnataka Bank* has notched a 106% higher Q3 EPS of Rs.9.7 and 119% higher 9M EPS of Rs.26, which may lead to FY23 EPS of Rs.37+ as against Rs.15.5 in FY22. Buy. Open / Comment

2023-02-19 15:04:13 *Garden Reach Shipbuilders & Engineers* has signed MoUs with 9 companies including Aerospace Engineers, Dynatron, Keltron, Naval Group (France), Rolls-Royce Solutions GmbH, and Tunga Aerospace Industries, for its various segments. Add at declines.

*Mishra Dhatu Nigam* has signed MoUs with 11 companies including HAL, Hindustan Shipyard, Micron Instruments, Bay Forge, and Welspun Speciality Steels, to develop and manufacture aerospace & naval materials, R&D, exports, healthcare and training. Buy at declines.

Debt-free *Lincoln Pharma* has notched Q3 EPS of Rs.10.8 and 9M EPS is Rs.30.1, which may lead to FY23 EPS of Rs.40+. Buy for 20% gain.

*Talbros Engineering* has notched 15% higher Q3 EPS of Rs.14.2 and 48% higher 9M EPS of Rs.43.6, which may lead to FY23 EPS of Rs.60. Buy for 25% gain.

*Dhunseri Ventures* has notched Q3 EPS of Rs.24.3 and 9M EPS of Rs.136, which may lead to FY23 EPS of Rs.160+ as against FY22 consolidated EPS of Rs.102.5. Buy for 30% gain.

*UltraTech Cement* commissions 1.3 MMTPA brownfield cement capacity in Chhattisgarh and 2.8 MMTPA greenfield grinding capacity in Odisha raising its capacity 126.95 MMTPA. Add on declines.

*Shreyans Industries* has notched 1720% higher Q3 EPS of Rs.14.6 and 356% higher 9M EPS of Rs.35.7 which could take FY23 EPS to Rs.50 as against Rs.7.2 in FY22. Buy for 30% gain.

*Glemark Pharma* ,a global leader in Generics, has 14 manufacturing facilities across India and notched Q3 EPS of Rs.9.7 and 9M EPS of Rs.25.7, which could take FY23 EPS to Rs 37+. Add.

*Bharat Forge* has signed an MOU with HAL foundry and Saarloha Advanced Materials to develop and produce aerospace grade steel alloys and application of new materials for use in the production of aircraft, engines and accessories.Add for the long term.

*Precision Wires’* expansion & modernization project at Silvassa to begin commercial production from March 2023 in stages/phases. Keep it on your radar.

*West Coast Paper Mills* is in a capex mode and notched 264% higher Q3 EPS of Rs.39.9 and 264% higher 9M EPS of Rs.101, which might take FY23 EPS to Rs.140. Buy for 30% gain.

*PaulMerchant*, has notched 9% higher Q3EPS of Rs.119.2 and 17% higher 9MEPS of Rs.346, which may take FY23 EPS to Rs.450 as against FY22 EPS of Rs.390.8. The scrip is a strong bonus candidate. Buy for 30% gain.

*Igarashi Motors* posted 9M loss of Rs.2.49 cr. However, its revenue grew 14% to Rs.488 cr. YOY resulting in a negative EPS of Rs.0.76. Sell now.

*Axiscades Technologies* posted Q1 & Q3 losses. For 9MFY23, it posted a loss of Rs.21.16 cr. as against a PAT of Rs.11.69 cr. during Q3FY22. Sell.

Cement industry is turning around with significant adjustment in input costs and higher sale prices. The best among the lot remains *Ultratech*.

*JK Laksmi Cement* is also a great investment too in the small & medium segment.

*Ugar Sugar* with the massive ethanol expansion may be re-rated. The early bird gets the worm.

*Globesecure Technologies,* the only listed co. in cyber security, to acquire stake in a cyber-security co. and enhance liquidity with current reduction in lot size. Add for good returns.

*Palred Technologies* is an undervalued counter in the wearable sector. Company has huge growth potential considering the incidental valuation gap and its products reach. Add.

*Cosmo Films* makes specialty films for packaging, lamination and labelling. Stock trades at 50% discount to year high and at just 7 PE. Buy for 30% gains in the short term.

*Cressanda Solutions* in software solutions specialised in AI/ML, digital media and ITeS has bagged a multi-year contract with Kolkata Metro to install LED screens and stream content in all coaches that will boost its working financials.

Money Times Talk is part of 'Money Times' publication. bs. Open / Comment

2023-02-19 15:04:12 *MONEY TIMES TALK*
*Dated 19 February 23*

*Dishman Carbogen’s* Q3 NP rose 33% YoY to Rs.46.946 cr. led by revenue growth of 14% to Rs.640 cr. Add.

Specialty Chemicals co., *TGV SRAAC,* posted 112% higher Q3 NP YoY and may post FY23 EPS of Rs 42. It trades at a PE of just 2.92x against industry average of 47x and P/B ratio of just 1.33x against industry average of 8.72x. Strong re-rating is in store.

*NALCO* posted Q3 NP of Rs.274 cr. as against Rs.170 cr. YoY. Although profit margins was hit, it registered a robust growth in production on all fronts. Accumulate.

Although *Bharat Dynamics’* Q3 was affected due to delays in receipt of critical electronic components, it looks good as alternate sources are being evaluated. Add on dips.

*Oil India* posted its best-ever Q3 with NP of Rs.2284.41 cr. A second interim dividend of Rs.10 has also been declared. Add.

*Sarda Energy & Minerals*’ Q3 EPS fell to Rs.36.99 from Rs.46.34 YoY. The share looks attractive at a P/BV ratio of 1.20x and a PE ratio of 6.35x. Add in small quantities.

Analysts believe *M&M* may sustain its outperformance driven by consistency in the automotive and tractor divisions with higher economies of scale. Add in small quantities.

*Nykaa* PAT declined 71% YoY to Rs.8.5 cr. in Q3, in spite of a rise in revenue by 33% to Rs.1463 cr. Sell.

*Adani group* is scouting for $1.5bn of ‘confidence capital’ from Abu Dhabi Investment Authority and other major investors. Better stay away from all Adani shares for now.

Since UK faces depleting ammunition reserves given the Ukraine-Russia war, Indian defense cos. *MTAR, HAL, and Mazagon Docks Shipbuilders* must be accumulated as 75% of our armaments would be sourced from Indian companies.

Brokerage firm, Jefferies, maintains that *RIL* has a 33% upside in one year, aided by its renewable energy business and other verticals. Add for the long term.

*ITC* to export up to Rs.2000 cr. worth of raw tobacco in FY24. The other divisions of ITC are also Accumulate.

*PFC’s* Q3 NP of Rs.5241.1 cr. led to an EPS of Rs.14.76 and Rs.42.47 for 9MFY23 and a third interim dividend of Rs.3.50. An FY23 EPS of Rs.57+ and a final dividend of Rs.7+ is a distinct possibility. The share is also a bonus candidate. Buy.

*Biocon* is in talks with PE investors to sell a stake in its arm to prune its debts and fund its acquisition of Viatris Inc. The share is available at a reasonable price. Accumulate.

Packaging dynamics are changing. While *Polyplex and Cosmo Films* posted subdued results, Uflex and Jindal Polyfilms posted losses. Hold the first two and exit the other two.

*Hero MotorCorp* to boost exports to 10% of sales. Add for the long term.

*MIDHANI’s* order book stands at Rs.1400 cr., which includes 40% from the defense sector. New orders worth Rs.500+ cr. likely from MOUs signed. Add.

*Amrutanjan* is facing serious allegations of financial malpractices. It also delivered unpleasant results for Q3. Sell.

*Bharat Electronics* and Israel Aerospace Industries to manufacture its Lora weapon systems for the Indian armed forces. Positive for the company. Add.

*Shilpa Medicare* has registered its Bengaluru facility with the UAE authorities to manufacture and test its Orodispersible films and Transdermal systems. Add in small lots.

Minda Corp has acquired 15.7% stake in Pricol for Rs.400 cr. Add *Pricol* at current rates.

*Geekay* notched 226% higher Q3 EPS of Rs.5.9 and 131% higher 9M EPS of Rs.11.5 and is all set to garner FY23 EPS of Rs.16+, backed by huge demand for its products. Buy for 30% gain.

*Repco Home Finance* posted 138% higher Q3 EPS of Rs.13.3 and 51% higher 9M EPS of Rs.37.1, which may lead to FY23 EPS of Rs.47+. Buy for 30% gain.

*Karnataka Bank* has notched a 106% higher Q3 EPS of Rs.9.7 and 119% higher 9M EPS of Rs.26, which may lead to FY23 EPS of Rs.37+ as against Rs.15.5 in FY22. Buy. Open / Comment

2023-02-17 12:14:39 Strongest sector also seeing selling ......fear in market Open / Comment

2023-02-17 10:17:01 Weakness in leading nifty sector is always sign of caution.....it lead to pull down....as we could not cross 18200 and no close above 18080 so be alert....dont be a mad bull....but be intelligent investor Open / Comment

2023-02-17 09:09:15 Bank Nifty looks weak Open / Comment